Bioage Labs, Stock Market Value
| BIOA Stock | 19.14 0.70 3.80% |
| Symbol | BioAge |
BioAge Labs, Price To Book Ratio
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioAge Labs, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAge Labs,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAge Labs,.
| 10/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in BioAge Labs, on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding BioAge Labs, or generate 0.0% return on investment in BioAge Labs, over 30 days. BioAge Labs, is related to or competes with Sea, FactSet Research, SunOpta, Getty Images, Cardinal Health, and BBB Foods. BioAmber Inc., an industrial biotechnology company, produces and sells renewable chemicals worldwide More
BioAge Labs, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAge Labs,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioAge Labs, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.92 | |||
| Information Ratio | 0.0227 | |||
| Maximum Drawdown | 26.47 | |||
| Value At Risk | (10.11) | |||
| Potential Upside | 8.26 |
BioAge Labs, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAge Labs,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAge Labs,'s standard deviation. In reality, there are many statistical measures that can use BioAge Labs, historical prices to predict the future BioAge Labs,'s volatility.| Risk Adjusted Performance | 0.044 | |||
| Jensen Alpha | 0.1652 | |||
| Total Risk Alpha | (0.63) | |||
| Sortino Ratio | 0.0214 | |||
| Treynor Ratio | 0.3634 |
BioAge Labs, Backtested Returns
BioAge Labs, appears to be somewhat reliable, given 3 months investment horizon. BioAge Labs, secures Sharpe Ratio (or Efficiency) of 0.0456, which signifies that the company had a 0.0456% return per unit of risk over the last 3 months. We have found thirty technical indicators for BioAge Labs,, which you can use to evaluate the volatility of the firm. Please makes use of BioAge Labs,'s Risk Adjusted Performance of 0.044, mean deviation of 4.21, and Downside Deviation of 5.92 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioAge Labs, holds a performance score of 3. The firm shows a Beta (market volatility) of 0.68, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioAge Labs,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding BioAge Labs, is expected to be smaller as well. Please check BioAge Labs,'s total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether BioAge Labs,'s price patterns will revert.
Auto-correlation | 0.50 |
Modest predictability
BioAge Labs, has modest predictability. Overlapping area represents the amount of predictability between BioAge Labs, time series from 25th of October 2024 to 9th of November 2024 and 9th of November 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAge Labs, price movement. The serial correlation of 0.5 indicates that about 50.0% of current BioAge Labs, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 1.51 |
BioAge Labs, lagged returns against current returns
Autocorrelation, which is BioAge Labs, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioAge Labs,'s stock expected returns. We can calculate the autocorrelation of BioAge Labs, returns to help us make a trade decision. For example, suppose you find that BioAge Labs, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioAge Labs, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioAge Labs, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioAge Labs, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioAge Labs, stock over time.
Current vs Lagged Prices |
| Timeline |
BioAge Labs, Lagged Returns
When evaluating BioAge Labs,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioAge Labs, stock have on its future price. BioAge Labs, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioAge Labs, autocorrelation shows the relationship between BioAge Labs, stock current value and its past values and can show if there is a momentum factor associated with investing in BioAge Labs,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioAge Labs, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs, Stock:Check out BioAge Labs, Correlation, BioAge Labs, Volatility and BioAge Labs, Alpha and Beta module to complement your research on BioAge Labs,. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
BioAge Labs, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.